Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock

Bias in meta-analysis detected by a simple, graphical test

1997 • 47,526 citations

Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis

1992 • 12,726 citations

Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock

2001 • 9,683 citations

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

2003 • 5,388 citations

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

2007 • 4,077 citations

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin

1991 • 1,611 citations

Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

1996 • 1,217 citations

Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coli

1982 • 1,062 citations

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1994 • 920 citations

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis

1997 • 822 citations

Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome

1995 • 805 citations

A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis

1991 • 741 citations

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome

1994 • 714 citations

Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.

1989 • 709 citations

Anti-inflammatory therapies to treat sepsis and septic shock

1997 • 656 citations

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

1998 • 618 citations

Inflammation: Basic Principles and Clinical Correlates

2000 • 616 citations

Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study

1999 • 537 citations

Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial

2003 • 534 citations

INTERSEPT

1996 • 492 citations

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial

1994 • 488 citations

Treatment of Septic Shock with Human Monoclonal Antibody HA-1A

1994 • 474 citations

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

1998 • 458 citations

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis

1993 • 427 citations

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock

1996 • 368 citations

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*

2004 • 365 citations

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin

1995 • 348 citations

Large Trials vs Meta-analysis of Smaller Trials

1996 • 337 citations

Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock

2002 • 316 citations

Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized Trial

1988 • 266 citations

Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock*

2007 • 260 citations

E5 Murine Monoclonal Antiendotoxin Antibody in Gram-Negative Sepsis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2000 • 256 citations

Anti-Endotoxin Monoclonal Antibodies

1992 • 235 citations

Predictive ability of meta-analyses of randomised controlled trials

1995 • 232 citations

Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: A systematic review and meta-analysis*

2007 • 220 citations

Score-based immunoglobulin G therapy of patients with sepsis: The SBITS study*

2007 • 208 citations

Meta-analysis: Intravenous Immunoglobulin in Critically Ill Adult Patients with Sepsis

2007 • 180 citations

Intravenous immunoglobulin for suspected or subsequently proven infection in neonates

2004 • 165 citations

Long-term survival after intensive care unit admission with sepsis

1995 • 159 citations

Randomized, Placebo‐Controlled Trial of HA‐1A, a Human Monoclonal Antibody to Endotoxin, in Children with Meningococcal Septic Shock

1999 • 159 citations

CDP571, a humanized antibody to human tumor necrosis factor-alpha

1995 • 152 citations

Adverse Effects of Intravenous Immunoglobulin Therapy

1999 • 140 citations

Polyclonal Immunoglobulin for Treatment of Bacterial Sepsis: A Systematic Review

2004 • 139 citations

Protein C and S deficiency in severe infectious purpura of children: A collaborative study of 40 cases

1992 • 136 citations

IgM-Enriched Intravenous Immunoglobulin Therapy in Neonatal Sepsis

1988 • 133 citations

ANTI-LIPOPOLYSACCHARIDE IMMUNOTHERAPY IN MANAGEMENT OF SEPTIC SHOCK OF OBSTETRIC AND GYNAECOLOGICAL ORIGIN

1984 • 126 citations

A Critical Evaluation of New Agents for the Treatment of Sepsis

1991 • 109 citations

Effectiveness of a Human Monoclonal Anti-Endotoxin Antibody (HA-1A) in Gram-Negative Sepsis: Relationship to Endotoxin and Cytokine Levels

1992 • 109 citations

Effects of High-Dose IgG on Survival of Surgical Patients With Sepsis Scores of 20 or Greater

1991 • 104 citations

Strategies for blocking the systemic effects of cytokines in the sepsis syndrome

1995 • 98 citations

Round table conference on clinical trials for the treatment of sepsis

1995 • 98 citations

Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis

1991 • 98 citations

Intravenous immune globulin therapy for early-onset sepsis in premature neonates

1992 • 93 citations

Intravenous Immunoglobulin Adjunctive Therapy in Sepsis, with Special Emphasis on Severe Invasive Group A Streptococcal Infections

2003 • 93 citations

Meta-analyses of the Effectiveness of Intravenous Immune Globulin for Prevention and Treatment of Neonatal Sepsis

1997 • 87 citations

Intravenous Polyclonal Immunoglobulin Administration to Sepsis Syndrome Patients: A Prospective Study in a Pediatric Intensive Care Unit

2005 • 86 citations

IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: A randomized, controlled, multiple-center trial*

2006 • 81 citations

Meningococcal Septic Shock in Children: Clinical and Laboratory Features, Outcome, and Development of a Prognostic Score

1997 • 78 citations

Immunoglobulin supplementation in prevention or treatment of neonatal sepsis

1986 • 77 citations

Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country

2005 • 76 citations

Plasma Tumor Necrosis Factor Levels in Patients With Presumed Sepsis

1989 • 74 citations

Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis

1992 • 73 citations

Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses.

1995 • 70 citations

Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis

1995 • 69 citations

The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830].

2002 • 69 citations

Intravenous immunoglobulins in association with antibiotics

1988 • 68 citations

Multicenter evaluation of a human monoclonal antibody to Entero-bacteriaceae common antigen in patients with Gram-negative sepsis

2003 • 59 citations

Comparison of Early IgM-Enriched Immunoglobulin vs Polyvalent IgG Administration in Score-Identified Postcardiac Surgical Patients at High Risk for Sepsis

1997 • 52 citations

Pathophysiology of Septic Shock and Multiple Organ Dysfunction Syndrome and Various Therapeutic Approaches with Special Emphasis on Immunoglobulins

2001 • 44 citations

Sepsis And Multiorgan Failure

1997 • 44 citations

Supplemental immune globulins in sepsis: a critical appraisal

1996 • 43 citations

High-Dose Intravenous IgG for Treatment of Severe Surgical Infections

1996 • 42 citations

Improving clinical trials in the critically ill: Unique challenge—Sepsis

2008 • 42 citations

Multicenter randomized placebo controlled trial of therapy with intravenous immunoglobulin in decreasing mortality due to neonatal sepsis.

1999 • 41 citations

Treatment of septic thrombocytopenia with immune globulin

1991 • 40 citations

Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, Gram-negative sepsis

1992 • 40 citations

Cooperative group of additional immunoglobulin therapy in severe bacterial infections: Results of a multicenter randomized controlled trial in cases of diffuse fibrinopurulent peritonitis

1987 • 40 citations

The use of IgM-enriched intravenous immunoglobulin for the treatment of neonatal sepsis in preterm infants.

1993 • 36 citations

Impact of Immunomodulating Therapy on Morbidity in Patients with Severe Sepsis

1999 • 36 citations

Immunoglobulin therapy in patients with endotoxemia and postoperative sepsis--a prospective randomized study.

1988 • 31 citations

Intravenous immunoglobulin in the treatment of full-term and premature newborns with sepsis.

1996 • 30 citations

[Immunoglobulin therapy of postoperative sepsis].

1990 • 26 citations

Intravenous Immunoglobulin in the Treatment of Salmonella Typhimurium Infections in Preterm Neonates

1994 • 25 citations

Pepsin‐Treated Human Gamma Globulin in Bacterial Infections: A Randomized Study in Patients with Septicaemia and Pneumonia

1981 • 21 citations

[Intravenous immunoglobulin in the treatment of neonatal septicemia].

1992 • 20 citations

Functional Antibacterial Activity of a Human Intravenous Immunoglobulin Preparation: in vitro and in vivo Studies

1983 • 19 citations

POLYVALENT IMMUNE GLOBULINS

1997 • 17 citations

Exchange transfusion or intravenous immunoglobulin therapy as an adjunct to antibiotics for neonatal sepsis in developing countries: a pilot study

2006 • 16 citations

An evaluation of the hemodynamic effects of HA-1A human monoclonal antibody

1994 • 13 citations

Treatment of Gram-Negative Septic Shock With an Immunoglobulin Preparation

1993 • 12 citations

The microbiology and outcome of sepsis in Victoria, Australia

2005 • 12 citations

Prophylactic anti-lipopolysaccharide freeze-dried plasma in major burns: a double blind controlled trial

1995 • 11 citations

Sepsis and polyspecific intravenous immunoglobulins

1997 • 11 citations

Antikörper gegen Lipoid A in der Behandlung des septischen Schocks

1987 • 10 citations

High doses of immunoglobulins decrease mortality rate of surgical patients with severe intraabdominal infections and sepsis.

1998 • 7 citations

Safety of Intravenous Immunoglobulin Infusion in Neonates at Risk for Sepsis

1990 • 6 citations

Sepsis and Multiorgan Failure

1998 • 5 citations

The significance of immunoglobulins in the treatment of patients with sepsis and septic shock.

1998 • 4 citations

Treatment of septic thrombocytopenia with immunoglobulin

2006 • 3 citations

[Clinical studies on the effectiveness of SM-4300, a new non-modified gammaglobulin preparation suitable for intravenous use, in refractory infections].

1985 • 2 citations

The Systemic Inflammatory Response Syndrome-Reply

1995 • 2 citations

[A clinical trial of SM-4300 against severe infections in surgery].

1985 • 2 citations

Author's Reply¹

1986 • 1 citations